Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 Dec;12(6):785–790. doi: 10.1111/j.1365-2125.1981.tb01307.x

Cimetidine increases steady state plasma levels of propranolol.

I W Reimann, U Klotz, B Siems, J Frölich
PMCID: PMC1401919  PMID: 7340880

Abstract

1 The influence of cimetidine (1000 mg daily) on propranolol steady state plasma levels has been studied in seven normal volunteers. Cimetidine was used as a 200 mg normal release tablet whereas propranolol was given as a 160 mg slow release formulation once daily. 2 After 1 day of cimetidine treatment (day 9 of the study) the mean (Css) and minimal (Css min) propranolol steady state plasma levels increased significantly from 24.1 +/- 14.9 ng/ml (mean +/- s.d.) to 39.2 +/- 27.7 ng/ml (P = 0.01) and from 14.8 +/- 9.3 ng/ml to 27.1 +/- 21.2 ng/ml (P = 0.03), respectively. The apparent oral clearance (Clo) was reduced from 6.7 +/- 4.3 l/min to 4.6 +/- 3.11/min (P = 0.006). 3 A prolongation of cimetidine administration to 5 days (day 13 of the study) intensified this effect significantly (P = 0.02): Css of propranolol was elevated from 23.2 +/- 14.4 ng/ml to 44.9 +/- 26.7 ng/ml (P = 0.003); Css min was increased from 14.1 +/- 10.2 ng/ml to 28.4 +/- 17.9 ng/ml (P = 0.02) while Clo decreased from 6.9 +/- 4.1 1/min to 3.3 +/- 1.61/min (P = 0.006). 4 We conclude that the drug interaction between propranolol and cimetidine leads to significant elevations of propranolol steady state plasma concentrations which may cause a clinically relevant enhancement of the effect of a given dosage. This requires careful observation of patients under concomitant treatment with propranolol and cimetidine.

Full text

PDF
786

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs. 1978 Feb;15(2):93–131. doi: 10.2165/00003495-197815020-00002. [DOI] [PubMed] [Google Scholar]
  2. Castleden C. M., George C. F., Short M. D. Contribution of individual differences in gastric emptying to variability in plasma propranolol concentrations. Br J Clin Pharmacol. 1978 Feb;5(2):121–122. doi: 10.1111/j.1365-2125.1978.tb01610.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Desmond P. V., Patwardhan R. V., Schenker S., Speeg K. V., Jr Cimetidine impairs elimination of chlordiazepoxide (Librium) in man. Ann Intern Med. 1980 Aug;93(2):266–268. doi: 10.7326/0003-4819-93-2-266. [DOI] [PubMed] [Google Scholar]
  4. Donovan M. A., Heagerty A. M., Patel L., Castleden M., Pohl J. E. Cimetidine and bioavailability of propranolol. Lancet. 1981 Jan 17;1(8212):164–164. doi: 10.1016/s0140-6736(81)90761-3. [DOI] [PubMed] [Google Scholar]
  5. Feely J., Wilkinson G. R., Wood A. J. Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med. 1981 Mar 19;304(12):692–695. doi: 10.1056/NEJM198103193041202. [DOI] [PubMed] [Google Scholar]
  6. Gardner S. K., Cady W. J., Ong Y. S. Effect of smoking on the elimination of propranolol hydrochloride. Int J Clin Pharmacol Ther Toxicol. 1980 Oct;18(10):421–424. [PubMed] [Google Scholar]
  7. Grabowski B. S., Cady W. J., Young W. W., Emery J. F. Effects of acute alcohol administration on propranolol absorption. Int J Clin Pharmacol Ther Toxicol. 1980 Jul;18(7):317–319. [PubMed] [Google Scholar]
  8. Klotz U., Reimann I. Delayed clearance of diazepam due to cimetidine. N Engl J Med. 1980 May 1;302(18):1012–1014. doi: 10.1056/NEJM198005013021807. [DOI] [PubMed] [Google Scholar]
  9. Klotz U., Reimann I. Influence of cimetidine on the pharmacokinetics of desmethyldiazepam and oxazepam. Eur J Clin Pharmacol. 1980 Nov;18(6):517–520. doi: 10.1007/BF00874666. [DOI] [PubMed] [Google Scholar]
  10. McAinsh J., Baber N. S., Holmes B. F., Young J., Ellis S. H. Bioavailability of sustained release propranolol formulations. Biopharm Drug Dispos. 1981 Jan-Mar;2(1):39–48. doi: 10.1002/bdd.2510020105. [DOI] [PubMed] [Google Scholar]
  11. Patwardhan R. V., Yarborough G. W., Desmond P. V., Johnson R. F., Schenker S., Speeg K. V., Jr Cimetidine spares the glucuronidation of lorazepam and oxazepam. Gastroenterology. 1980 Nov;79(5 Pt 1):912–916. [PubMed] [Google Scholar]
  12. Puurunen J., Pelkonen O. Cimetidine inhibits microsomal drug metabolism in the rat. Eur J Pharmacol. 1979 May 1;55(3):335–336. doi: 10.1016/0014-2999(79)90205-x. [DOI] [PubMed] [Google Scholar]
  13. Puurunen J., Sotaniemi E., Pelkonen O. Effect of cimetidine on microsomal drug metabolism in man. Eur J Clin Pharmacol. 1980 Aug;18(2):185–187. doi: 10.1007/BF00561588. [DOI] [PubMed] [Google Scholar]
  14. Rees M. R., Clark R. A., Holdsworth C. D., Barber D. C., Howlett P. J. The effect of beta-adrenoceptor agonists and antagonists on gastric emptying in man. Br J Clin Pharmacol. 1980 Dec;10(6):551–554. doi: 10.1111/j.1365-2125.1980.tb00509.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rendić S., Sunjić V., Toso R., Kajfez F., Ruf H. H. Interaction of cimetidine with liver microsomes. Xenobiotica. 1979 Sep;9(9):555–564. doi: 10.3109/00498257909042321. [DOI] [PubMed] [Google Scholar]
  16. Routledge P. A., Shand D. G. Clinical pharmacokinetics of propranolol. Clin Pharmacokinet. 1979 Mar-Apr;4(2):73–90. doi: 10.2165/00003088-197904020-00001. [DOI] [PubMed] [Google Scholar]
  17. Serlin M. J., Sibeon R. G., Mossman S., Breckenridge A. M., Williams J. R., Atwood J. L., Willoughby J. M. Cimetidine: interaction with oral anticoagulants in man. Lancet. 1979 Aug 18;2(8138):317–319. doi: 10.1016/s0140-6736(79)90340-4. [DOI] [PubMed] [Google Scholar]
  18. Walle T., Gaffney T. E. Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites. J Pharmacol Exp Ther. 1972 Jul;182(1):83–92. [PubMed] [Google Scholar]
  19. Wood A. J., Carr K., Vestal R. E., Belcher S., Wilkinson G. R., Shand D. G. Direct measurement of propranolol bioavailability during accumulation to steady-state. Br J Clin Pharmacol. 1978 Oct;6(4):345–350. doi: 10.1111/j.1365-2125.1978.tb00862.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES